AN EXAMINATION OF LOW AVERAGE DOSE AS A QUALITY MEASURE OF THE NEED FOR ANTICOAGULATION MANAGEMENT AMONG THE ELDERLY

Author(s)

Benjamin F Banahan III, PhD, Principal Scientist, Noel E Wilkin, PhD, RPh, Interim Associate Provost, Clive M Mendonca, RPh, Graduate Assistant University of Mississippi, University, MS, USA

Objective: The objective was to evaluate the relationship between low dose warfarin therapy and hospital utilization. This information will help to evaluate this as a quality of care indicator in elderly patients. Methods: An issue in chronic warfarin therapy is the availability of time and resources necessary to adequately manage patients on anticoagulation therapy. Providers may err on the side of under-dosing due to fears of bleeding episodes. Medicare Part D and A records for 2006 were pulled for all non-ESRD, chronic warfarin users in California, Florida, and Mississippi age 65+. Chronic warfarin users were defined as patients with 3+ warfarin prescriptions covering 180+ days of therapy. Average dose was computed by dividing the total mgs of warfarin dispensed from the first prescription to the next to last prescription and dividing by the number of days between the first and last prescription fills. Low average dose was defined as

Conference/Value in Health Info

2008-05, ISPOR 2008, Toronto, Ontario, Canada

Value in Health, Vol. 11, No. 3 (May/June 2008)

Code

PIH28

Topic

Economic Evaluation, Health Service Delivery & Process of Care, Specialized Treatment Areas

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies, Hospital and Clinical Practices, Personalized & Precision Medicine, Quality of Care Measurement, Treatment Patterns and Guidelines

Disease

Geriatrics

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×